Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Phys Biol ; 17(6): 065001, 2020 09 22.
Artículo en Inglés | MEDLINE | ID: mdl-32959788

RESUMEN

Epidemiological models usually contain a set of parameters that must be adjusted based on available observations. Once a model has been calibrated, it can be used as a forecasting tool to make predictions and to evaluate contingency plans. It is customary to employ only point estimators of model parameters for such predictions. However, some models may fit the same data reasonably well for a broad range of parameter values, and this flexibility means that predictions stemming from them will vary widely, depending on the particular values employed within the range that gives a good fit. When data are poor or incomplete, model uncertainty widens further. A way to circumvent this problem is to use Bayesian statistics to incorporate observations and use the full range of parameter estimates contained in the posterior distribution to adjust for uncertainties in model predictions. Specifically, given an epidemiological model and a probability distribution for observations, we use the posterior distribution of model parameters to generate all possible epidemic curves, whose information is encapsulated in posterior predictive distributions. From these, one can extract the worst-case scenario and study the impact of implementing contingency plans according to this assessment. We apply this approach to the evolution of COVID-19 in Mexico City and assess whether contingency plans are being successful and whether the epidemiological curve has flattened.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/epidemiología , Epidemias , Neumonía Viral/epidemiología , Teorema de Bayes , COVID-19 , Infecciones por Coronavirus/mortalidad , Bases de Datos Factuales , Epidemias/estadística & datos numéricos , Humanos , Conceptos Matemáticos , México/epidemiología , Modelos Biológicos , Modelos Estadísticos , Pandemias , Neumonía Viral/mortalidad , Probabilidad , SARS-CoV-2 , Factores de Tiempo , Incertidumbre
2.
J Theor Biol ; 248(4): 608-17, 2007 Oct 21.
Artículo en Inglés | MEDLINE | ID: mdl-17669435

RESUMEN

One-third of the world population (approximately 2 billion individuals) is currently infected with Mycobacterium tuberculosis, the vast majority harboring a latent infection. As the risk of reactivation is around 10% in a lifetime, it follows that 200 million of these will eventually develop active pulmonary disease. Only therapeutic or post-exposure interventions can tame this vast reservoir of infection. Treatment of latent infections can reduce the risk of reactivation, and there is accumulating evidence that combination with post-exposure vaccines can reduce the risk of reinfection. Here we develop mathematical models to explore the potential of these post-exposure interventions to control tuberculosis on a global scale. Intensive programs targeting recent infections appear generally effective, but the benefit is potentially greater in intermediate prevalence scenarios. Extending these strategies to longer-term persistent infections appears more beneficial where prevalence is low. Finally, we consider that susceptibility to reinfection is altered by therapy, and explore its epidemiological consequences. When we assume that therapy reduces susceptibility to subsequent reinfection, catastrophic dynamics are observed. Thus, a bipolar outcome is obtained, where either small or large reductions in prevalence levels result, depending on the rate of detection and treatment of latent infections. By contrast, increased susceptibility after therapy may induce an increase in disease prevalence and does not lead to catastrophic dynamics. These potential outcomes are silent unless a widespread intervention is implemented.


Asunto(s)
Modelos Biológicos , Tuberculosis/inmunología , Tuberculosis/prevención & control , Antituberculosos/uso terapéutico , Portador Sano/inmunología , Humanos , Prevención Secundaria , Tuberculosis/transmisión , Vacunas contra la Tuberculosis
3.
Microbes Infect ; 7(4): 593-9, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15820150

RESUMEN

Measles and pertussis are ubiquitous vaccine-preventable diseases, which remain an important public health problem in developing countries. Hence, developing a deep understanding of their transmission dynamics remains imperative. To achieve this, we compared the impact of vaccination at both individual and population levels in a Senegalese rural community. This study represents the first such comparative study in tropical conditions and constitutes a point of comparison with other studies of disease dynamics in developed countries. Changes in the transmission rates of infections are reflected in their mean ages at infection and basic reproductive ratio calculated before and after vaccination. We explored persistence of both infections in relation to population size in each village and found the inter-epidemic period for the whole area using wavelets analysis. As predicted by epidemiological theory, we observed an increase in the mean age at infection and a decrease in the reproductive ratio of both diseases. We showed for both the pre- vaccination and vaccine eras that persistence depends on population size. After vaccination, persistence decreased and the inter-epidemic period increased. The observed changes suggest that vaccination against measles and pertussis induced a drop in their transmission. Similarities in disease dynamics to those of temperate regions such as England and Wales were also observed.


Asunto(s)
Brotes de Enfermedades/prevención & control , Vacuna Antisarampión/administración & dosificación , Sarampión/epidemiología , Vacuna contra la Tos Ferina/administración & dosificación , Población Rural , Tos Ferina/epidemiología , Adolescente , Bordetella pertussis/inmunología , Niño , Preescolar , Humanos , Incidencia , Lactante , Sarampión/prevención & control , Virus del Sarampión/inmunología , Densidad de Población , Senegal/epidemiología , Vacunación , Tos Ferina/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA